top of page
All Posts
Adara Bio Advances R&D Pipeline: Signs Strategic Collaboration Agreement with TFBS Bioscience at Bio Asia–Taiwan 2026
Melbourne based Adara Bio which is building the next generation of retinal genetic medicines through a programmable RNA editing platform today announced a collaboration with viral vector manufacturer TFBS Bioscience to support its pre-clinical research.
Adara Bio
Jul 202 min read
bottom of page